Olema Pharmaceuticals OLMA Balance Sheet (2020-2026)

NASDAQ OLMA
$10.75 +0.02 (+0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Olema Pharmaceuticals Quarterly Balance Sheet

Periods 26 quarters
Latest Jun 2026

Olema Pharmaceuticals reported total assets of $486.58M and total liabilities of $56.01M for the quarter ended Jun 2026, up 27.4% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
0.15M0.22M0.31M0.39M0.48M0.58M0.68M0.74M0.70M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
25.60M13.81M21.51M24.53M26.80M23.70M40.92M34.96M117.41M68.54M33.72M16.89M35.89M139.48M50.64M52.47M35.26M48.30M52.55M48.60M
Receivables - OtherOther Receivables
0.13M0.46M0.32M0.30M0.22M0.42M0.67M0.66M0.82M0.69M2.12M1.92M1.83M2.05M3.14M3.32M2.85M
Prepaid Assets
2.33M3.44M2.35M2.31M2.46M4.48M3.44M4.07M5.11M4.71M3.11M3.08M3.23M4.39M3.96M5.81M5.37M10.02M7.88M8.81M
Current Assets
308.28M290.69M270.21M243.03M225.06M208.90M189.40M171.51M282.01M266.51M252.09M242.19M217.99M438.47M396.66M367.73M334.33M515.45M513.23M469.88M
Non-Current Assets
Property, Plant & Equipment (Net)
0.97M1.47M1.42M1.45M1.40M1.48M1.38M1.27M1.06M0.97M1.03M0.94M0.85M0.75M0.65M0.56M0.49M0.27M0.36M0.38M
Other Non-Current Assets
0.54M0.54M2.79M3.10M2.77M4.25M2.77M2.90M7.18M8.14M9.55M10.56M10.61M11.19M11.92M12.59M16.70M16.83M16.50M16.06M
Non-Current Assets
1.51M5.26M7.20M7.57M6.94M6.75M6.37M6.12M10.79M10.43M11.60M12.37M12.18M12.51M12.98M14.28M18.12M17.98M17.42M16.70M
Assets
309.80M295.94M277.42M250.60M232.00M215.65M195.77M177.62M292.80M276.94M263.69M254.56M230.17M450.98M409.64M382.00M352.45M533.43M530.64M486.58M
Liabilities
Current Liabilities
Accounts Payables
0.31M0.02M0.27M0.12M0.01M0.37M0.68M1.62M2.21M2.70M7.66M4.35M2.69M4.46M0.15M0.93M3.47M9.25M3.72M1.67M
Payables
0.31M0.02M0.27M0.12M0.01M0.37M0.68M1.62M2.21M2.70M7.66M4.35M2.69M4.46M0.15M0.93M3.47M9.25M3.72M1.67M
Accumulated Expenses
2.11M3.75M1.02M2.05M2.93M4.52M2.74M12.41M12.84M5.46M1.25M2.50M3.79M5.66M1.62M3.39M5.29M8.25M2.77M4.48M
Other Accumulated Expenses
8.60M8.06M9.02M11.11M11.45M15.16M17.82M9.03M8.37M17.93M17.51M21.08M26.88M36.13M24.89M31.08M37.01M41.42M42.49M50.69M
Current Leases
0.93M0.88M1.08M1.08M1.01M0.91M0.80M0.92M0.99M1.06M1.10M1.14M1.17M1.02M1.15M1.17M1.12M0.96M0.66M
Current Taxes
0.02M
Total Current Liabilities
8.90M9.02M10.17M12.31M12.55M16.55M19.41M14.83M15.97M21.62M26.22M26.54M30.70M41.76M26.06M33.16M41.66M51.80M47.17M53.01M
Non-Current Liabilities
Non-Current Debt
3.00M3.00M3.00M3.00M3.00M
Operating Leases
2.36M2.16M2.01M1.75M1.55M1.38M1.21M1.70M1.43M1.15M0.86M0.56M0.26M0.12M0.60M0.31M0.07M
Total Liabilities
8.90M11.38M12.33M14.32M14.30M18.10M20.79M16.04M17.66M23.05M27.38M27.39M31.26M42.02M26.19M36.77M44.97M54.87M50.17M56.01M
Shareholder's Equity
Total Debt
3.00M3.00M3.00M3.00M3.00M
Common Equity
300.89M284.57M265.09M236.28M217.70M197.55M174.97M161.58M275.13M253.90M236.32M227.16M198.91M408.96M383.45M345.24M307.49M478.56M480.48M430.56M
Liabilities and Shareholders Equity
309.80M295.94M277.42M250.60M232.00M215.65M195.77M177.62M292.80M276.94M263.69M254.56M230.17M450.98M409.64M382.00M352.45M533.43M530.64M486.58M
Retained Earnings
383.43M388.90M393.93M398.76M403.17M408.33M413.21M419.46M554.23M559.18M572.93M594.26M599.98M843.92M848.52M854.19M858.45M1,075.49M1,131.58M1,145.35M
Treasury Shares